Cardiology Today

CURRENTLY VIEWING:

The following articles appeared in the print edition of CARDIOLOGY TODAY.

Table of Contents
Commentary

Electrophysiology training in crisis

Peter R. Kowey, MD, FACC, FAHA, FHRS; Victoria M. Robinson, MBChB, MRCP; Douglas Esberg, MD, FACC, FHRS

5 Questions

Andrea M. Russo, MD, emphasizes importance of learning, collaboration

Cardiometabolic Conversations

Weight loss recommended to decrease CV risk in metabolically healthy obesity

Cover Story

HF pharmacotherapy in midst of paradigm shift

FDA News

FDA approves canagliflozin to treat diabetic kidney disease, heart failure hospitalization

Feature

New trials elevate focus on polypill strategy for CVD prevention

In the Journals

Sleep duration may be predictive of cardiometabolic risk factors, cerebrovascular disease mortality

Children exposed to secondhand smoke at home at greater risk for AF

Fluoroquinolones pose risk for aortic, mitral regurgitation

Meeting News

Twice-yearly inclisiran injection shows durable LDL improvement: ORION-11

Subclinical leaflet thrombosis not tied to serious clinical events: PARTNER 3 CT substudy

Salt substitute reduced hypertension incidence by 55% in Peru

HiSTORIC: Troponin I-based risk stratification safely identifies low-risk patients

TWILIGHT: Switching to ticagrelor monotherapy 3 months post-PCI lowers bleeding vs. DAPT

Next Gen Innovators expound on highlights from TCT

Rivaroxaban monotherapy noninferior to combo therapy for AF, stable CAD

SCOPE I: Acurate neo does not meet noninferiority for TAVR safety, efficacy vs. Sapien 3

Pharmacology Consult

CV controversy of ADHD medication use in children and adolescents

Sarah Mehringer, PharmD, BCPS, BCCP; Myaa Lightfoot, PharmD; Katie Liveoak, PharmD, BCPP; Jonathan Bain, PharmD, BCCCP, BCPS (AQ Cardiology)

Trial Scorecards

TWILIGHT

Look AHEAD

ATTEST

HELP-AF

GALACTIC

EARNEST-PVI

SCOPE I

IDEAL-LM